Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience.
HPV vaccine
LEEP
cervical dysplasia
prevention
recurrence
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Jan 2020
25 Jan 2020
Historique:
received:
08
12
2019
revised:
14
01
2020
accepted:
22
01
2020
entrez:
30
1
2020
pubmed:
30
1
2020
medline:
30
1
2020
Statut:
epublish
Résumé
The aim of this study was to assess the role of a human papilloma virus (HPV) vaccine after loop electrosurgical excision procedure (LEEP) in reducing recurrent cervical dysplasia. A series of 503 women with cervical dysplasia received LEEP between January 2012 and October 2018. Of these patients, 379 were treated between January 2012 and June 2017, thus ensuring an adequate follow-up time. We made three attempts to establish telephone contact with each patient; 77 women did not respond and were excluded from the final study population, which consisted of 302 patients. One hundred eighty-two (60.7%) women were vaccinated with an HPV vaccine within 4 weeks of LEEP and 103 (34.3%) were followed up with but not vaccinated. Recurrence of cervical dysplasia requiring a further LEEP procedure occurred in 30 (10.5%) women, of whom 17 (16.5%) were not vaccinated and 13 (7.1%) were vaccinated (
Identifiants
pubmed: 31991753
pii: vaccines8010045
doi: 10.3390/vaccines8010045
pmc: PMC7157656
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Gynecol Oncol. 2019 Nov;30(6):e119
pubmed: 31576704
Crit Rev Oncol Hematol. 2018 Feb;122:92-97
pubmed: 29458794
Cancer Res. 2002 Dec 1;62(23):7075-82
pubmed: 12460929
Int J Gynecol Cancer. 2008 Jan-Feb;18(1):90-4
pubmed: 17506849
Clin Infect Dis. 2012 Apr;54(7):891-8
pubmed: 22291111
Mol Ther. 2003 Nov;8(5):762-8
pubmed: 14599809
Gynecol Oncol. 2006 Nov;103(2):631-6
pubmed: 16780934
Arch Gynecol Obstet. 2018 Dec;298(6):1205-1210
pubmed: 30306310
BMC Cancer. 2015 Oct 20;15:744
pubmed: 26486312
Gynecol Oncol. 2018 Nov;151(2):229-234
pubmed: 30197061
J Natl Cancer Inst. 2001 Feb 21;93(4):284-92
pubmed: 11181775
Clin Cancer Res. 2002 Dec;8(12):3676-85
pubmed: 12473576
J Gynecol Oncol. 2019 Nov;30(6):e88
pubmed: 31576684
Gynecol Oncol. 2017 Jul;146(1):196-204
pubmed: 28442134
BMJ. 2012 Mar 27;344:e1401
pubmed: 22454089
Gynecol Oncol. 2010 Jun;118(1 Suppl):S12-7
pubmed: 20494219
Gynecol Oncol. 2013 Aug;130(2):264-8
pubmed: 23623831
N Engl J Med. 2015 Feb 19;372(8):711-23
pubmed: 25693011
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Cancer Res. 2003 Nov 1;63(21):7215-20
pubmed: 14612516
BJOG. 2008 Sep;115(10):1238-42
pubmed: 18715408
Lancet Glob Health. 2016 Jul;4(7):e453-63
pubmed: 27340003
Am J Obstet Gynecol. 2016 Aug;215(2):212.e1-212.e15
pubmed: 26892991